{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:54:49Z","timestamp":1792691689466,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360067"],"award-info":[{"award-number":["82360067"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260278"],"award-info":[{"award-number":["82260278"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91774-7","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T16:24:37Z","timestamp":1742487877000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Anticoagulation therapy after reperfusion treatment for acute ischemic stroke with non-valvular atrial fibrillation: a multicenter retrospective study"],"prefix":"10.1038","volume":"15","author":[{"given":"Fang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangbin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingmin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinghao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianglong","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"key":"91774_CR1","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1161\/CIRCRESAHA.116.308407","volume":"120","author":"H Kamel","year":"2017","unstructured":"Kamel, H. & Healey, J. S. Cardioembolic stroke. Circ. Res. 120, 514\u2013526 (2017).","journal-title":"Circ. Res."},{"key":"91774_CR2","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1586\/erc.09.77","volume":"7","author":"NJJ MacDougall","year":"2009","unstructured":"MacDougall, N. J. J., Amarasinghe, S. & Muir, K. W. Secondary prevention of stroke. Expert Rev. Cardiovasc. Ther. 7, 1103\u20131115 (2009).","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"91774_CR3","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1161\/CIRCRESAHA.114.303211","volume":"114","author":"J Andrade","year":"2014","unstructured":"Andrade, J., Khairy, P., Dobrev, D. & Nattel, S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ. Res. 114, 1453\u20131468 (2014).","journal-title":"Circ. Res."},{"key":"91774_CR4","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1161\/01.STR.27.10.1760","volume":"27","author":"HJ Lin","year":"1996","unstructured":"Lin, H. J. et al. Stroke severity in atrial fibrillation. The Framingham study. Stroke 27, 1760\u20131764 (1996).","journal-title":"Stroke"},{"key":"91774_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jns.2019.06.007","volume":"403","author":"AT Bjerkreim","year":"2019","unstructured":"Bjerkreim, A. T. et al. Five-year readmission and mortality differ by ischemic stroke subtype. J. Neurol. Sci. 403, 31\u201337 (2019).","journal-title":"J. Neurol. Sci."},{"key":"91774_CR6","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","volume":"49","author":"WJ Powers","year":"2018","unstructured":"Powers, W. J. et al. 2018 guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 49, e46\u2013e110 (2018).","journal-title":"Stroke"},{"key":"91774_CR7","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1161\/01.CIR.84.2.933","volume":"84","author":"JA Cairns","year":"1991","unstructured":"Cairns, J. A. Stroke prevention in atrial fibrillation trial. Circulation 84, 933\u2013935 (1991).","journal-title":"Circulation"},{"key":"91774_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000185.pub2","author":"R Saxena","year":"2004","unstructured":"Saxena, R. & Koudstaal, P. J. Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack. Cochrane Database Syst. Rev. https:\/\/doi.org\/10.1002\/14651858.CD000185.pub2 (2004).","journal-title":"Cochrane Database Syst. Rev."},{"key":"91774_CR9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart, R. G., Pearce, L. A. & Aguilar, M. I. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann. Intern. Med. 146, 857\u2013867 (2007).","journal-title":"Ann. Intern. Med."},{"key":"91774_CR10","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/ana.25489","volume":"85","author":"DJ Seiffge","year":"2019","unstructured":"Seiffge, D. J. et al. Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation. Ann. Neurol. 85, 823\u2013834 (2019).","journal-title":"Ann. Neurol."},{"key":"91774_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1161\/01.STR.0000254600.92975.1f","volume":"38","author":"M Paciaroni","year":"2007","unstructured":"Paciaroni, M., Agnelli, G., Micheli, S. & Caso, V. Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials. Stroke 38, 423\u2013430 (2007).","journal-title":"Stroke"},{"key":"91774_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/2047487316676037","volume":"24","author":"B Gorenek","year":"2017","unstructured":"Gorenek, B. et al. European heart rhythm association (EHRA)\/European association of cardiovascular prevention and rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the heart rhythm society (HRS) and Asia Pacific heart rhythm society (APHRS). Eur. J. Prev. Cardiol. 24, 4\u201340 (2017).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"91774_CR13","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers, W. J. et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke\u2014A guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 50, e344\u2013e418 (2019).","journal-title":"Stroke"},{"key":"91774_CR14","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1161\/STROKEAHA.115.008891","volume":"46","author":"M Paciaroni","year":"2015","unstructured":"Paciaroni, M. et al. Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation: Effect of anticoagulation and its timing\u2014The RAF study. Stroke 46, 2175\u20132182 (2015).","journal-title":"Stroke"},{"key":"91774_CR15","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.122.060666","volume":"146","author":"J Oldgren","year":"2022","unstructured":"Oldgren, J. et al. Early versus delayed non-vitamin K antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation (TIMING): A registry-based randomized controlled noninferiority study. Circulation 146, 1056\u20131066 (2022).","journal-title":"Circulation"},{"key":"91774_CR16","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2303048","volume":"388","author":"U Fischer","year":"2023","unstructured":"Fischer, U. et al. Early versus later anticoagulation for stroke with atrial fibrillation. N. Engl. J. Med. 388, 2411\u20132421 (2023).","journal-title":"N. Engl. J. Med."},{"key":"91774_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/jamaneurol.2023.4430","volume":"81","author":"D Sun","year":"2024","unstructured":"Sun, D. et al. Alberta stroke program early computed tomography score, infarct core volume, and endovascular therapy outcomes in patients with large infarct: A secondary analysis of the ANGEL-ASPECT trial. JAMA Neurol. 81, 30\u201338 (2024).","journal-title":"JAMA Neurol."},{"key":"91774_CR18","doi-asserted-by":"publisher","first-page":"e037234","DOI":"10.1136\/bmjopen-2020-037234","volume":"10","author":"I Escudero-Martinez","year":"2020","unstructured":"Escudero-Martinez, I. et al. Dabigatran initiation in patients with non-valvular AF and first acute ischaemic stroke: a retrospective observational study from the SITS registry. BMJ Open 10, e037234 (2020).","journal-title":"BMJ Open"},{"key":"91774_CR19","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1007\/s00415-022-11515-y","volume":"270","author":"H Ma","year":"2023","unstructured":"Ma, H. et al. The optimum anticoagulation time after endovascular thrombectomy for atrial fibrillation-related large vessel occlusion stroke: a real-world study. J. Neurol. 270, 2084\u20132095 (2023).","journal-title":"J. Neurol."},{"key":"91774_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411587","volume":"372","author":"OA Berkhemer","year":"2015","unstructured":"Berkhemer, O. A. et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N. Engl. J. Med. 372, 11\u201320 (2015).","journal-title":"N. Engl. J. Med."},{"key":"91774_CR21","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa1414792","volume":"372","author":"BCV Campbell","year":"2015","unstructured":"Campbell, B. C. V. et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N. Engl. J. Med. 372, 1009\u20131018 (2015).","journal-title":"N. Engl. J. Med."},{"key":"91774_CR22","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1056\/NEJMoa1503780","volume":"372","author":"TG Jovin","year":"2015","unstructured":"Jovin, T. G. et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N. Engl. J. Med. 372, 2296\u20132306 (2015).","journal-title":"N. Engl. J. Med."},{"key":"91774_CR23","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1056\/NEJMoa1415061","volume":"372","author":"JL Saver","year":"2015","unstructured":"Saver, J. L. et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N. Engl. J. Med. 372, 2285\u20132295 (2015).","journal-title":"N. Engl. J. Med."},{"key":"91774_CR24","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1212\/WNL.0000000000003283","volume":"87","author":"DJ Seiffge","year":"2016","unstructured":"Seiffge, D. J. et al. Early start of DOAC after ischemic stroke: Risk of intracranial hemorrhage and recurrent events. Neurology 87, 1856\u20131862 (2016).","journal-title":"Neurology"},{"key":"91774_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0140-6736(07)60149-4","volume":"369","author":"N Wahlgren","year":"2007","unstructured":"Wahlgren, N. et al. Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST): An observational study. Lancet Lond. Engl. 369, 275\u2013282 (2007).","journal-title":"Lancet Lond. Engl."},{"key":"91774_CR26","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(98)08020-9","volume":"352","author":"W Hacke","year":"1998","unstructured":"Hacke, W. et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet Lond. Engl. 352, 1245\u20131251 (1998).","journal-title":"Lancet Lond. Engl."},{"key":"91774_CR27","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/SLA.0000000000001797","volume":"265","author":"G Lonjon","year":"2017","unstructured":"Lonjon, G., Porcher, R., Ergina, P., Fouet, M. & Boutron, I. Potential pitfalls of reporting and bias in observational studies with propensity score analysis assessing a surgical procedure: A methodological systematic review. Ann. Surg. 265, 901\u2013909 (2017).","journal-title":"Ann. Surg."},{"key":"91774_CR28","first-page":"463","volume":"23","author":"Atrial Fibrillation Stroke Prevention and Control Specialized Committee","year":"2019","unstructured":"Atrial Fibrillation Stroke Prevention and Control Specialized Committee et al. Guidline on prevention and treatment of cardiogenic stroke (2019). Chin. J. Cardiac. Arrhyth. 23, 463\u2013484 (2019).","journal-title":"Chin. J. Cardiac. Arrhyth."},{"key":"91774_CR29","doi-asserted-by":"publisher","first-page":"oead051","DOI":"10.1093\/ehjopen\/oead051","volume":"3","author":"AJ Camm","year":"2023","unstructured":"Camm, A. J. et al. Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: Results from GARFIELD-AF. Eur. Heart J. Open 3, oead051 (2023).","journal-title":"Eur. Heart J. Open"},{"key":"91774_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ijcard.2008.10.045","volume":"139","author":"K-L Chien","year":"2010","unstructured":"Chien, K.-L. et al. Atrial fibrillation prevalence, incidence and risk of stroke and all-cause death among Chinese. Int. J. Cardiol. 139, 173\u2013180 (2010).","journal-title":"Int. J. Cardiol."},{"key":"91774_CR31","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff, C. T. et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet Lond. Engl. 383, 955\u2013962 (2014).","journal-title":"Lancet Lond. Engl."},{"key":"91774_CR32","doi-asserted-by":"crossref","unstructured":"Sj, C. et al. Dabigatran versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 361 (2009).","DOI":"10.1056\/NEJMc0909962"},{"key":"91774_CR33","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel, M. R. et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N. Engl. J. Med. 365, 883\u2013891 (2011).","journal-title":"N. Engl. J. Med."},{"key":"91774_CR34","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano, R. P. et al. Edoxaban versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 369, 2093\u20132104 (2013).","journal-title":"N. Engl. J. Med."},{"key":"91774_CR35","first-page":"808","volume":"111","author":"GJ Hankey","year":"2014","unstructured":"Hankey, G. J. Unanswered questions and research priorities to optimise stroke prevention in atrial fibrillation with the new oral anticoagulants. Thromb. Haemost. 111, 808\u2013816 (2014).","journal-title":"Thromb. Haemost."},{"key":"91774_CR36","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger, C. B. et al. Apixaban versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 365, 981\u2013992 (2011).","journal-title":"N. Engl. J. Med."},{"key":"91774_CR37","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","volume":"333","author":"National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","year":"1995","unstructured":"National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333, 1581\u20131587 (1995).","journal-title":"N. Engl. J. Med."},{"key":"91774_CR38","doi-asserted-by":"publisher","first-page":"e018003","DOI":"10.1161\/JAHA.120.018003","volume":"10","author":"C Geng","year":"2021","unstructured":"Geng, C. et al. Endovascular thrombectomy versus bridging thrombolysis: Real-world efficacy and safety analysis based on a nationwide registry study. J. Am. Heart Assoc. 10, e018003 (2021).","journal-title":"J. Am. Heart Assoc."},{"key":"91774_CR39","doi-asserted-by":"publisher","first-page":"e007034","DOI":"10.1161\/JAHA.117.007034","volume":"6","author":"M Paciaroni","year":"2017","unstructured":"Paciaroni, M. et al. Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with non-vitamin-K oral anticoagulants (RAF-NOACs) study. J. Am. Heart Assoc. 6, e007034 (2017).","journal-title":"J. Am. Heart Assoc."},{"key":"91774_CR40","doi-asserted-by":"publisher","first-page":"107823","DOI":"10.1016\/j.clineuro.2023.107823","volume":"231","author":"BG de Liyis","year":"2023","unstructured":"de Liyis, B. G., Surya, S. C., Tedyanto, E. H., Pramana, N. A. K. & Widyadharma, I. P. E. Mechanical thrombectomy in M1 and M2 segments of middle cerebral arteries: A meta-analysis of prospective cohort studies. Clin. Neurol. Neurosurg. 231, 107823 (2023).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"91774_CR41","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/1747493016632239","volume":"11","author":"S Arihiro","year":"2016","unstructured":"Arihiro, S. et al. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The samurai-nonvalvular atrial fibrillation (NVAF) study. Int. J. Stroke Off. J. Int. Stroke Soc. 11, 565\u2013574 (2016).","journal-title":"Int. J. Stroke Off. J. Int. Stroke Soc."},{"key":"91774_CR42","doi-asserted-by":"crossref","unstructured":"Lc, G. et al. Early rivaroxaban use after cardioembolic stroke may not result in hemorrhagic transformation: A prospective magnetic resonance imaging study. Stroke 47 (2016).","DOI":"10.1161\/STROKEAHA.116.013491"},{"key":"91774_CR43","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","volume":"384","author":"J Emberson","year":"2014","unstructured":"Emberson, J. et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: A meta-analysis of individual patient data from randomised trials. Lancet Lond. Engl. 384, 1929\u20131935 (2014).","journal-title":"Lancet Lond. Engl."},{"key":"91774_CR44","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1212\/WNL.0000000000002199","volume":"85","author":"MV Mazya","year":"2015","unstructured":"Mazya, M. V. et al. IV thrombolysis in very severe and severe ischemic stroke: Results from the SITS-ISTR Registry. Neurology 85, 2098\u20132106 (2015).","journal-title":"Neurology"},{"key":"91774_CR45","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","volume":"387","author":"M Goyal","year":"2016","unstructured":"Goyal, M. et al. Endovascular thrombectomy after large-vessel ischaemic stroke: A meta-analysis of individual patient data from five randomised trials. Lancet Lond. Engl. 387, 1723\u20131731 (2016).","journal-title":"Lancet Lond. Engl."},{"key":"91774_CR46","doi-asserted-by":"publisher","first-page":"e200107","DOI":"10.1001\/jamanetworkopen.2020.0107","volume":"3","author":"KAA Fox","year":"2020","unstructured":"Fox, K. A. A. et al. Outcomes associated with oral anticoagulants plus antiplatelets in patients with newly diagnosed atrial fibrillation. JAMA Netw. Open 3, e200107 (2020).","journal-title":"JAMA Netw. Open"},{"key":"91774_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11883-019-0790-x","volume":"21","author":"B Mac Grory","year":"2019","unstructured":"Mac Grory, B., Flood, S., Schrag, M., Paciaroni, M. & Yaghi, S. anticoagulation resumption after stroke from atrial fibrillation. Curr. Atheroscler. Rep. 21, 29 (2019).","journal-title":"Curr. Atheroscler. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91774-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91774-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91774-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T20:02:25Z","timestamp":1742587345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91774-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91774"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91774-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The experiment had been approved by the Ethics Committee (O-Medical Research Ethics [2023] No. 35) of The Second Affiliated Hospital of Nanchang University, Nanchang, China. The study was carried out in accordance with the principles of the Declaration of Helsinki. All subjects were informed of study details and signed informed consent prior to study inclusion.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research ethics and patient consent"}}],"article-number":"9619"}}